Gene expression analysis in cell lines by RT-PCR
. | HOP . | HOXB9 . | HLXB9 . | HOXB4* . | mir-196a1 . |
---|---|---|---|---|---|
HL | |||||
HD-70 | NE† | +† | NE† | +† | NE† |
HDLM-2 | +† | +† | +† | +† | +† |
KM-H2 | +† | +† | +† | ++† | +† |
L-1236 | –† | +† | +† | ++† | +† |
L-428 | –† | +† | +† | ++† | +† |
L-540 | +† | +† | –† | +† | +† |
SUP-HD1 | +† | +† | +† | ++† | +† |
ALCL | |||||
DEL | – | –† | +† | +† | NE† |
FE-PD | NE | +† | –† | NE† | NE† |
KARPAS-299 | – | +† | –† | +† | +† |
JB6 | – | –† | +† | +† | NE† |
KI-JK | – | –† | +† | +† | NE† |
MAC2A | – | +† | +† | +† | NE† |
SR-786 | – | –† | +† | +† | +† |
SU-DHLI | NE | +† | NE† | NE† | NE† |
SUP-M2 | + | +† | +† | ++† | +† |
MLBCL | |||||
KARPAS-1106P | NE | +† | –† | +† | NE |
MedB-1 | – | +† | +† | +† | NE |
DLCL/FL | |||||
DB | – | – | +† | – | NE |
DOHH2 | – | – | +† | – | NE |
KARPAS-422 | – | – | +† | + | – |
KIS-1 | NE | – | –† | + | – |
OCI-LY-19 | NE | – | +† | NE | NE |
RC-K8 | – | + | +† | – | + |
RI-1 | – | – | +† | – | – |
SBH-1 | – | – | +† | NE | NE |
SC-1 | – | – | +† | – | – |
SU-DHL-4 | – | – | –† | – | NE |
WSU-NHL | – | – | –† | – | NE |
MCL | |||||
GRANTA-519 | NE | + | – | +† | NE |
JEKO-1 | – | – | – | +† | NE |
BL | |||||
BL-41 | – | – | – | +† | – |
BL-70 | – | – | – | –† | – |
DAUDI | – | – | – | ++† | – |
DG-75 | NE | – | – | NE† | NE |
NAMALWA | – | + | – | –† | NE |
RAJI | – | – | – | ++ | NE |
NKTL | |||||
DERL-7 | – | + | – | +† | NE |
Other BCL | |||||
380 | NE | NE | NE | +† | NE |
AMO-I | NE | – | – | ++† | NE |
CI-I | + | – | – | ++† | NE |
CRO-AP3 | – | + | – | –† | NE |
JVM-13 | – | + | – | –† | NE |
L-591 | – | – | – | ++† | NE |
LP-1 | – | – | – | –† | NE |
MC-116 | + | – | – | +† | NE |
MUTZ-5 | NE | + | – | NE† | NE |
NALM-6 | NE | – | – | NE† | NE |
SU-DHL-16 | – | – | – | –† | – |
TANOUE | – | – | – | –† | NE |
TS-2 | NE | – | NE | NE† | NE |
U-266 | – | – | – | ++† | NE |
U-698 | – | – | NE | NE† | NE |
TCL | |||||
ALL-SIL | – | – | – | –† | – |
CCRF-CEM | – | – | – | +† | – |
HD-MAR | – | – | – | –† | – |
HPB-ALL | – | – | – | –† | NE |
KE-37 | – | – | – | ++† | NE |
MOLT-4 | – | NE | NE | +† | – |
MOLT-14 | – | – | – | +† | – |
PEER | NE | – | – | +† | NE |
TALL-1 | – | – | – | +† | NE |
TALL-104 | NE | – | NE | NE† | NE |
Myeloid | |||||
CMK-1 | – | – | – | ++† | NE |
GDM-1 | + | – | + | ++† | – |
HD-MYZ | – | – | – | NE† | NE |
HL60 | – | – | – | –† | NE |
HMC-1 | – | + | NE | +† | + |
K-562 | – | + | NE | ++† | NE |
KASUMI-1 | – | – | – | –† | NE |
KG-1 | + | + | – | –† | NE |
M-07e | – | – | – | ++† | NE |
MonoMac-1 | – | – | – | –† | – |
MOLM-16 | – | + | NE | NE† | NE |
MOLM-17 | + | – | NE | +† | NE |
MUTZ-2 | – | – | – | –† | NE |
MUTZ-3 | – | – | – | –† | NE |
MUTZ-11 | – | NE | NE | +† | + |
NB-4 | – | – | – | –† | – |
NOMO-1 | – | – | – | +† | NE |
OCIAML2 | + | – | – | –† | NE |
TF-1 | – | + | – | –† | – |
THP-1 | – | – | – | +† | NE |
U-937 | – | – | – | –† | NE |
Controls | |||||
CD34+ | + | – | – | ++ | NE |
MRC-5 | – | – | – | NE | NE |
NC-NC | – | – | – | + | NE |
PBC | + | – | – | ++ | – |
Solid tumors | |||||
293 | – | + | – | + | NE |
BPH-1 | – | NE | – | – | NE |
CAPAN-1 | – | – | – | – | NE |
HELA | – | – | + | + | NE |
HT-1080 | – | + | NE | + | NE |
LN-405 | NE | + | NE | – | NE |
LN-CAP | – | NE | + | NE | NE |
NTERA2 | – | – | – | – | NE |
PC-3 | NE | + | + | NE | NE |
. | HOP . | HOXB9 . | HLXB9 . | HOXB4* . | mir-196a1 . |
---|---|---|---|---|---|
HL | |||||
HD-70 | NE† | +† | NE† | +† | NE† |
HDLM-2 | +† | +† | +† | +† | +† |
KM-H2 | +† | +† | +† | ++† | +† |
L-1236 | –† | +† | +† | ++† | +† |
L-428 | –† | +† | +† | ++† | +† |
L-540 | +† | +† | –† | +† | +† |
SUP-HD1 | +† | +† | +† | ++† | +† |
ALCL | |||||
DEL | – | –† | +† | +† | NE† |
FE-PD | NE | +† | –† | NE† | NE† |
KARPAS-299 | – | +† | –† | +† | +† |
JB6 | – | –† | +† | +† | NE† |
KI-JK | – | –† | +† | +† | NE† |
MAC2A | – | +† | +† | +† | NE† |
SR-786 | – | –† | +† | +† | +† |
SU-DHLI | NE | +† | NE† | NE† | NE† |
SUP-M2 | + | +† | +† | ++† | +† |
MLBCL | |||||
KARPAS-1106P | NE | +† | –† | +† | NE |
MedB-1 | – | +† | +† | +† | NE |
DLCL/FL | |||||
DB | – | – | +† | – | NE |
DOHH2 | – | – | +† | – | NE |
KARPAS-422 | – | – | +† | + | – |
KIS-1 | NE | – | –† | + | – |
OCI-LY-19 | NE | – | +† | NE | NE |
RC-K8 | – | + | +† | – | + |
RI-1 | – | – | +† | – | – |
SBH-1 | – | – | +† | NE | NE |
SC-1 | – | – | +† | – | – |
SU-DHL-4 | – | – | –† | – | NE |
WSU-NHL | – | – | –† | – | NE |
MCL | |||||
GRANTA-519 | NE | + | – | +† | NE |
JEKO-1 | – | – | – | +† | NE |
BL | |||||
BL-41 | – | – | – | +† | – |
BL-70 | – | – | – | –† | – |
DAUDI | – | – | – | ++† | – |
DG-75 | NE | – | – | NE† | NE |
NAMALWA | – | + | – | –† | NE |
RAJI | – | – | – | ++ | NE |
NKTL | |||||
DERL-7 | – | + | – | +† | NE |
Other BCL | |||||
380 | NE | NE | NE | +† | NE |
AMO-I | NE | – | – | ++† | NE |
CI-I | + | – | – | ++† | NE |
CRO-AP3 | – | + | – | –† | NE |
JVM-13 | – | + | – | –† | NE |
L-591 | – | – | – | ++† | NE |
LP-1 | – | – | – | –† | NE |
MC-116 | + | – | – | +† | NE |
MUTZ-5 | NE | + | – | NE† | NE |
NALM-6 | NE | – | – | NE† | NE |
SU-DHL-16 | – | – | – | –† | – |
TANOUE | – | – | – | –† | NE |
TS-2 | NE | – | NE | NE† | NE |
U-266 | – | – | – | ++† | NE |
U-698 | – | – | NE | NE† | NE |
TCL | |||||
ALL-SIL | – | – | – | –† | – |
CCRF-CEM | – | – | – | +† | – |
HD-MAR | – | – | – | –† | – |
HPB-ALL | – | – | – | –† | NE |
KE-37 | – | – | – | ++† | NE |
MOLT-4 | – | NE | NE | +† | – |
MOLT-14 | – | – | – | +† | – |
PEER | NE | – | – | +† | NE |
TALL-1 | – | – | – | +† | NE |
TALL-104 | NE | – | NE | NE† | NE |
Myeloid | |||||
CMK-1 | – | – | – | ++† | NE |
GDM-1 | + | – | + | ++† | – |
HD-MYZ | – | – | – | NE† | NE |
HL60 | – | – | – | –† | NE |
HMC-1 | – | + | NE | +† | + |
K-562 | – | + | NE | ++† | NE |
KASUMI-1 | – | – | – | –† | NE |
KG-1 | + | + | – | –† | NE |
M-07e | – | – | – | ++† | NE |
MonoMac-1 | – | – | – | –† | – |
MOLM-16 | – | + | NE | NE† | NE |
MOLM-17 | + | – | NE | +† | NE |
MUTZ-2 | – | – | – | –† | NE |
MUTZ-3 | – | – | – | –† | NE |
MUTZ-11 | – | NE | NE | +† | + |
NB-4 | – | – | – | –† | – |
NOMO-1 | – | – | – | +† | NE |
OCIAML2 | + | – | – | –† | NE |
TF-1 | – | + | – | –† | – |
THP-1 | – | – | – | +† | NE |
U-937 | – | – | – | –† | NE |
Controls | |||||
CD34+ | + | – | – | ++ | NE |
MRC-5 | – | – | – | NE | NE |
NC-NC | – | – | – | + | NE |
PBC | + | – | – | ++ | – |
Solid tumors | |||||
293 | – | + | – | + | NE |
BPH-1 | – | NE | – | – | NE |
CAPAN-1 | – | – | – | – | NE |
HELA | – | – | + | + | NE |
HT-1080 | – | + | NE | + | NE |
LN-405 | NE | + | NE | – | NE |
LN-CAP | – | NE | + | NE | NE |
NTERA2 | – | – | – | – | NE |
PC-3 | NE | + | + | NE | NE |
ALCL indicates anaplastic large cell lymphoma; MLBCL, mediastinal large B-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MBCL, mediastinal B-cell lymphoma; BL, Burkitt lymphoma; NKTL, natural killer T-cell lymphoma; BCL, B-cell lymphoma/leukemia; TCL, T-cell leukemia; PBC, peripheral blood cells (PBCs); NE, no tested expression; +, positive expression; ++, strong expression; –, negative expression.
HOXB4 expression was judged quantitatively.
Lymphoma/leukemia entities with at least 50% positive tested cell lines.